216 related articles for article (PubMed ID: 22151409)
1. Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.
Moesgaard SG; Klostergaard C; Zois NE; Teerlink T; Molin M; Falk T; Rasmussen CE; Luis Fuentes V; Jones ID; Olsen LH
J Vet Intern Med; 2012; 26(1):61-8. PubMed ID: 22151409
[TBL] [Abstract][Full Text] [Related]
2. Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.
Reimann MJ; Møller JE; Häggström J; Martinussen T; Zatrazemi SSC; Svanholm L; Nielsen LBM; Pedersen HD; Olsen LH
J Vet Intern Med; 2017 Jul; 31(4):1008-1016. PubMed ID: 28573754
[TBL] [Abstract][Full Text] [Related]
3. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
[TBL] [Abstract][Full Text] [Related]
4. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
[TBL] [Abstract][Full Text] [Related]
5. Decreased platelet function in Cavalier King Charles Spaniels with mitral valve regurgitation.
Tarnow I; Kristensen AT; Texel H; Olsen LH; Pedersen HD
J Vet Intern Med; 2003; 17(5):680-6. PubMed ID: 14529135
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
Sudunagunta S; Green D; Christley R; Dukes-McEwan J
J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of natriuretic peptides in dogs with mitral valve disease.
Tarnow I; Olsen LH; Kvart C; Hoglund K; Moesgaard SG; Kamstrup TS; Pedersen HD; Häggström J
Vet J; 2009 May; 180(2):195-201. PubMed ID: 18675567
[TBL] [Abstract][Full Text] [Related]
8. Intermittent mitral regurgitation in Cavalier King Charles spaniels: Short-term progression and influence of stress tests.
Reimann MJ; Møller JE; Häggström J; Åkerström LLB; Martinussen T; Olsen LH
Vet J; 2020 Apr; 258():105457. PubMed ID: 32564867
[TBL] [Abstract][Full Text] [Related]
9. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
[TBL] [Abstract][Full Text] [Related]
10. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study.
Pedersen HD; Kristensen BO; Lorentzen KA; Koch J; Jensen AL; Flagstad A
Can J Vet Res; 1995 Oct; 59(4):294-8. PubMed ID: 8548691
[TBL] [Abstract][Full Text] [Related]
11. Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs.
Pedersen LG; Tarnow I; Olsen LH; Teerlink T; Pedersen HD
Res Vet Sci; 2006 Jun; 80(3):336-42. PubMed ID: 16182327
[TBL] [Abstract][Full Text] [Related]
12. Advanced electrocardiographic parameters change with severity of mitral regurgitation in Cavalier King Charles Spaniels in sinus rhythm.
Spiljak Pakkanen M; Domanjko Petrič A; Olsen LH; Stepančič A; Schlegel TT; Falk T; Rasmussen CE; Starc V
J Vet Intern Med; 2012; 26(1):93-100. PubMed ID: 22168834
[TBL] [Abstract][Full Text] [Related]
13. Decreased plasma concentration of nitric oxide metabolites in dogs with untreated mitral regurgitation.
Pedersen HD; Schütt T; Søndergaard R; Qvortrup K; Olsen LH; Kristensen AT
J Vet Intern Med; 2003; 17(2):178-84. PubMed ID: 12683618
[TBL] [Abstract][Full Text] [Related]
14. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
[TBL] [Abstract][Full Text] [Related]
15. Increased platelet aggregation response in Cavalier King Charles Spaniels with mitral valve prolapse.
Olsen LH; Kristensen AT; Häggström J; Jensen AL; Klitgaard B; Hansson H; Pedersen HD
J Vet Intern Med; 2001; 15(3):209-16. PubMed ID: 11380029
[TBL] [Abstract][Full Text] [Related]
16. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
Häggström J; Hansson K; Kvart C; Karlberg BE; Vuolteenaho O; Olsson K
Am J Vet Res; 1997 Jan; 58(1):77-82. PubMed ID: 8989501
[TBL] [Abstract][Full Text] [Related]
17. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.
Zois NE; Moesgaard SG; Kjelgaard-Hansen M; Rasmussen CE; Falk T; Fossing C; Häggström J; Pedersen HD; Olsen LH
Vet J; 2012 Apr; 192(1):106-11. PubMed ID: 21696985
[TBL] [Abstract][Full Text] [Related]
18. Assessment of changes in hemostatic markers in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Tarnow I; Kristensen AT; Olsen LH; Pedersen HD
Am J Vet Res; 2004 Dec; 65(12):1644-52. PubMed ID: 15631028
[TBL] [Abstract][Full Text] [Related]
19. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
[TBL] [Abstract][Full Text] [Related]
20. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
Ljungvall I; Höglund K; Lilliehöök I; Oyama MA; Tidholm A; Tvedten H; Häggström J
J Vet Intern Med; 2013; 27(5):1105-12. PubMed ID: 23865457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]